These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3344394)

  • 1. [Vaccines obtained by genetic engineering].
    Tron F
    Rev Prat; 1988 Jan; 38(1):45-9. PubMed ID: 3344394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccines in the biotechnologic era].
    Mazana J; Ariño M
    Enferm Infecc Microbiol Clin; 1990; 8(6):368-75. PubMed ID: 2081174
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered human vaccines.
    Sandhu JS
    Crit Rev Biotechnol; 1994; 14(1):1-27. PubMed ID: 8187202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some aspects in the development of vaccines against acute respiratory tract disease].
    Süss I; Schmidt S
    Z Gesamte Hyg; 1987 Oct; 33(10):487-9. PubMed ID: 3433828
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biotechnology vaccines--development of new disease prevention. Research progress of Biocine in Siena--HIV, herpes, Helicobacter].
    Keil TU
    Fortschr Med; 1994 Apr; 112(11):53-4. PubMed ID: 8200601
    [No Abstract]   [Full Text] [Related]  

  • 8. Live virus vaccines: something old, something new, something borrowed..
    Dubensky TW; Polo JM; Liu MA
    Nat Med; 1998 Dec; 4(12):1357-8. PubMed ID: 9846565
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
    Gałazka A
    Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
    [No Abstract]   [Full Text] [Related]  

  • 11. The iscom antigen-presenting system.
    Morein B
    Nature; 1988 Mar; 332(6161):287-8. PubMed ID: 3347272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine developments.
    Lancet; 1991 Apr; 337(8745):824-5. PubMed ID: 1672919
    [No Abstract]   [Full Text] [Related]  

  • 13. Chimeric virus-like particles as vaccines.
    Krüger DH; Ulrich R; Gerlich WH
    Biol Chem; 1999 Mar; 380(3):275-6. PubMed ID: 10223328
    [No Abstract]   [Full Text] [Related]  

  • 14. Transgenic plants as edible vaccines.
    Richter L; Kipp PB
    Curr Top Microbiol Immunol; 1999; 240():159-76. PubMed ID: 10394720
    [No Abstract]   [Full Text] [Related]  

  • 15. [The prospects for the development of viral vaccines].
    Bektimirov TA; Gorbunov MA
    Voen Med Zh; 1995 Jul; (7):45-8. PubMed ID: 7571512
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward the development of vectored vaccines in compliance with evolutionary medicine.
    Tang DC; Van Kampen KR
    Expert Rev Vaccines; 2008 May; 7(4):399-402. PubMed ID: 18444885
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant Salmonella vectors in vaccine development.
    Curtiss R; Kelly SM; Tinge SA; Tacket CO; Levine MM; Srinivasan J; Koopman M
    Dev Biol Stand; 1994; 82():23-33. PubMed ID: 7958478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines: how, why, and when?
    Johns Hopkins Med Lett Health After 50; 2002 May; 14(3):6-7. PubMed ID: 12004837
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface bacterial antigen CS31A as a tool to design new recombinant vaccines displaying heterologous antigenic determinants.
    Martin C; Girardeau JP; Der Vartanian M; Méchin MC; Bousquet F; Bertin Y; Laude H; Contrepois M
    Vet Res; 1995; 26(3):209-10. PubMed ID: 7540912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.